3 Global Stocks That May Be Trading Below Estimated Value In July 2026

In July 2026, global markets are experiencing a complex landscape marked by geopolitical tensions in the Middle East, fluctuating oil prices, and concerns over AI investment returns. Amidst these challenges, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to navigate this volatile environment. A good stock in such conditions is one that demonstrates strong fundamentals and resilience against economic uncertainties.

Top 10 Undervalued Stocks Based On Cash Flows

Name	Current Price	Fair Value (Est)	Discount (Est)
Visional (TSE:4194)	¥8713.00	¥17385.55	49.9%
Micro Systemation (OM:MSAB B)	SEK86.40	SEK172.02	49.8%
Matrix Design (SZSE:301365)	CN¥36.64	CN¥73.09	49.9%
Lotes (TWSE:3533)	NT$1855.00	NT$3668.77	49.4%
GreenEnergy (TSE:1436)	¥1374.00	¥2746.62	50%
Elite Material (TWSE:2383)	NT$4745.00	NT$9407.04	49.6%
Dustin Group (OM:DUST)	SEK1.808	SEK3.59	49.6%
Centiel (SWX:CNTL)	CHF6.16	CHF12.25	49.7%
Casta Diva Group (BIT:CDG)	€3.00	€6.00	50%
CanSino Biologics (SEHK:6185)	HK$23.18	HK$46.00	49.6%

Click here to see the full list of 456 stocks from our Undervalued Global Stocks Based On Cash Flows screener.

Let's take a closer look at a couple of our picks from the screened companies.

Demant (CPSE:DEMANT)

Overview: Demant A/S is a hearing healthcare company with operations across Europe, North America, Asia, the Pacific region, and internationally, boasting a market cap of DKK60.23 billion.

Operations: The company generates revenue from its Hearing Healthcare segment, which amounts to DKK22.97 billion.

Estimated Discount To Fair Value: 45.2%

Demant is trading at DKK285.6, significantly below its estimated future cash flow value of DKK521.55, highlighting potential undervaluation based on discounted cash flow analysis. Despite a high debt level, Demant's earnings and revenue are forecast to grow faster than the Danish market, with expected annual profit growth of 12.41%. Recent leadership changes aim to enhance strategic focus and leverage cross-business collaboration for further value creation under CEO Søren Nielsen's guidance.

• In light of our recent growth report, it seems possible that Demant's financial performance will exceed current levels.
• Click here and access our complete balance sheet health report to understand the dynamics of Demant.

Ningbo Orient Wires & CablesLtd (SHSE:603606)

Overview: Ningbo Orient Wires & Cables Co., Ltd. is involved in the research, development, manufacturing, and sale of submarine and terrestrial cable products both in China and internationally, with a market cap of CN¥33.45 billion.

Operations: The company's revenue is primarily derived from the production and sale of submarine and terrestrial cables, serving both domestic and international markets.

Estimated Discount To Fair Value: 25.7%

Ningbo Orient Wires & Cables Ltd. is trading at CN¥41.15, below its estimated future cash flow value of CN¥55.36, suggesting undervaluation based on discounted cash flow analysis. Despite an unstable dividend track record, the company has shown strong earnings growth of 32.8% over the past year and is forecast to continue growing profitably at a significant rate annually, with analysts anticipating a 49.8% stock price increase in line with rising revenue expectations.

• Upon reviewing our latest growth report, Ningbo Orient Wires & CablesLtd's projected financial performance appears quite optimistic.
• Take a closer look at Ningbo Orient Wires & CablesLtd's balance sheet health here in our report.

Shanghai United Imaging Healthcare (SHSE:688271)

Overview: Shanghai United Imaging Healthcare Co., Ltd. operates in the medical imaging and radiotherapy equipment sector with a market cap of CN¥95.53 billion.

Operations: The company's revenue is primarily derived from its medical imaging diagnostic equipment and radiotherapy equipment segment, which generated CN¥14.23 billion.

Estimated Discount To Fair Value: 22.6%

Shanghai United Imaging Healthcare trades at CN¥115.52, below its estimated future cash flow value of CN¥149.17, indicating potential undervaluation. Earnings grew by 49.6% last year and are expected to rise significantly over the next three years, outpacing the market with a forecasted annual growth of 25.2%. Recent strategic moves include a share buyback and expansion in North America through advanced imaging technologies, reinforcing its commitment to innovation and market presence.

• Our earnings growth report unveils the potential for significant increases in Shanghai United Imaging Healthcare's future results.
• Get an in-depth perspective on Shanghai United Imaging Healthcare's balance sheet by reading our health report here.

Make It Happen

• Navigate through the entire inventory of 456 Undervalued Global Stocks Based On Cash Flows here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com